Table:
text: Marine pharmacognosy
Compounds from Marine Sources in Clinical Level
Clinical Pipeline of Marine Pharmacology, July 2011. From http://marinepharmacology.midwestern.edu/clinPipeline.htm
Clinical_Status Compound_Name Trademark Marine_Organism_α Chemical_Class Molecular_Target Clinical_Trials_β Disease_Area
Phase III Plitidepsin Aplidin ® Tunicate Depsipeptide Rac1 and JNK Activation 1/7 Cancer
Phase II DMXBA (GTS-21) N/A Worm Alkaloid Alpha-7 Nicotinic Acetylcholine Receptor 0/3 Congnition , Schizophrenia
Phase II Plinabulin (NPI 2358) N/A Fungus Diketopiperazine Microtubules and JNK Stress Protein 1/2 Cancer
Phase II Elisidepsin Irvalec ® Mollusk Depsipeptide Plasma Membrane Fluidity 1/2 Cancer
Phase II PM00104 Zalypsis ® Nudibranch Alkaloid DNA-Binding 2/3 Cancer
Phase II Glembatumumab Vedotin (CDX-011) N/A Mollusk Antibody Drug Conjugate (MM Auristatin E) Glycoprotein NMB and Microtubules 1/3 Cancer
Phase I Marizomib (Salinosporamide A) N/A Bacterium Beta-Lactone-Gamma Lactam 20S Proteasome 4/4 Cancer
Phase I PM01183 N/A Tunicate Alkaloid Minor Groove of DNA N/A Cancer

text: Marine pharmacognosy
Compounds from Marine Sources in Clinical Level
Clinical Pipeline of Marine Pharmacology, July 2011. From http://marinepharmacology.midwestern.edu/clinPipeline.htm
Clinical_Status Compound_Name Trademark Marine_Organism_α Chemical_Class Molecular_Target Clinical_Trials_β Disease_Area
FDA-Approved Cytarabine (Ara-C) Cytosar-U ® Sponge Nucleoside DNA Polymerase >50/711 Cancer
FDA-Approved Vidarabine (Ara-A) Vira-A ® Sponge Nucleoside Viral DNA Polymerase 0 Antiviral
FDA-Approved Ziconotide Prialt ® Cone Snail Peptide N-Type Ca 2+ Channel 2/5 Analgesic
FDA-Approved Eribulin Mesylate (E7389) Halaven ® Sponge Macrolide s Microtubule 19/27 Cancer
FDA-Approved Omega-3-Fatty Acid Ethyl Esters Lovaza ® Fish Omega-3 Fatty Acids Triglyceride -Synthesizing Enzymes 45/94 Hypertriglyceridemia
FDA-Approved Trabectedin (ET-743) EU Approved only Yondelis ® Tunicate Alkaloid Minor Groove of DNA 17/34 Cancer
Phase III Brentuximab Vedotin (SGN-35) Adcetris ® Mollusk Antibody-Drug Conjugate (MM Auristatin E) CD30 and Microtubules 9/19 Cancer

text: Marine pharmacognosy
Compounds from Marine Sources in Clinical Level
Clinical Pipeline of Marine Pharmacology, July 2011. From http://marinepharmacology.midwestern.edu/clinPipeline.htm
Clinical_Status Compound_Name Trademark Marine_Organism_α Chemical_Class Molecular_Target Clinical_Trials_β Disease_Area
Phase I SGN-75 N/A Mollusk Antibody Drug Conjugate (MM Auristatin F) CD70 and Microtubules 2/2 Cancer
Phase I ASG-5ME N/A Mollusk Antibody Drug Conjugate (MM auristatin E) ASG-5 and Microtubules 2/2 Cancer
Phase I Hemiasterlin (E7974) N/A Sponge Tripeptide Microtubules 0/3 Cancer
Phase I Bryostatin 1 N/A Bryozoa Polyketide Protein Kinase C 0/38 Cancer, Alzheimers

Question: How many brands list a DNA minor groove molecular target and phase i clinical status value for marine pharmacognosy?